Antioxidant SOD mimetic prevents NADPH oxidase-induced oxidative stress and renal damage in the early stage of experimental diabetes and hypertension

American Journal of Nephrology

Volumn 29, Issue 4, 2009, Pages 309-318

  Peixoto, Elisa B M I ^a   Pessoa, Bruno S ^a   Biswas, Subrata K ^a   Lopes De Faria, Jose B ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Albuminuria; Diabetic nephropathy; Extracellular matrix; Hypertension; Oxidative stress; Spontaneously hypertensive rats; Tempol

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALBUMIN; COLLAGEN TYPE 4; CREATININE; DNA; NITRATE; NITRITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TEMPOL;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETIC HYPERTENSION; DIABETIC NEPHROPATHY; DNA DAMAGE; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STREPTOZOCIN DIABETES;

ANIMALS; ANTIOXIDANTS; COLLAGEN TYPE IV; CYCLIC N-OXIDES; DEOXYGUANOSINE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; HYPERTENSION, RENAL; KIDNEY; MALE; MOLECULAR MIMICRY; NADPH OXIDASE; OXIDATIVE STRESS; RATS; RATS, INBRED SHR; SPIN LABELS; SUPEROXIDE DISMUTASE;

EID: 53449089230     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000163767     Document Type: Article

References (57)

1. Tarnow L, Rossing P, Gall MA, Nielsen FS, Parving HH: Prevalence of arterial hypertension in diabetic patients before and after JNC-V. Diabetes Care 1994; 17: 1247-1251.
2. Stratton IM, Cull CA, Adler AI, Matthews DR, Neil HA, Holman RR: Additive effects of glycemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia 2006; 49: 1761-1769.
3. UK Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317: 703-713.
4. Thomas MC, Atkins RC: Blood pressure lowering for the prevention and treatment of diabetic kidney disease. Drugs 2006; 66: 213-2234.
5. Wolf G: New insights into the pathophysiology of diabetic nephropathy: from haemodynamics to molecular pathology. Eur J Clin Invest 2004; 34: 785-796.
6. Giunti S, Barit D, Cooper ME: Mechanisms of diabetic nephropathy: role of hypertension. Hypertension 2006; 48: 519-526.
7. Hinokio Y, Suzuki S, Hirai M, Suzuki C, Toyota T: Urinary excretion of 8-oxo-7,8-dihydro- 2' -deoxyguanosine as a predictor of the development of diabetic nephropathy. Diabetologia 002; 45: 877-882.
8. Beisswenger PJ, Drummond KS, Nelson RG, Howell SK, Szwergold BS, Mauer M: Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stress. Diabetes 2005; 54: 3274-3281.
9. Biswas SK, Peixoto EBMI, Souza DS, Lopes de Faria JB: Hypertension increases pro-oxidant generation and decreases antioxidant defense in the kidney in early diabetes. Am J Nephrol 2008; 28: 133-142.
10. Biswas SK, Lopes de Faria JB: Hypertension induces oxidative stress but not macrophage infiltration in the kidney in the early stage of experimental diabetes mellitus. Am J Nephrol 2006; 26: 415-422.
11. Prabhakar S, Starnes J, Shi S, Lonis S, Tran R: Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production. J Am Soc Nephrol 2007; 18: 2945-2952.
12. Biswas SK, Lopes de Faria JB: Which comes first: renal inflammation or oxidative stress in spontaneously hypertensive rats? Free Radic Res 2007; 41: 216-224.
13. Wardle EN: Cellular oxidative processes in relation to renal disease. Am J Nephrol 2005; 25: 13-22.
14. Jones DP: Redefining oxidative stress. Antioxid Redox Signal 2006; 8: 1865-1879.
15. Scandalios JG: Oxidative stress: molecular erception and transduction of signals triggering antioxidant gene defenses. Braz J Med Biol Res 2005; 38: 995-1014.
16. Gill PS, Wilcox CS: NADPH oxidase in the kidney. Antioxid Redox Signal 2006; 8: 1597-1607.
17. Gorin Y, Block K, Hernandez J, Bhandari B, Wagner B, Barnes JL, Abboud HE: Nox4 AD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J Biol Chem 2005; 280: 39616-39626.
18. Asaba K, Tojo A, Onozato ML, Goto A, Fujita T: Double-edged action of SOD mimetic in diabetic nephropathy. J Cardiovasc Pharmacol 2007; 49: 13-19.
19. Xia L, Wang H, Goldberg HJ, Munk S, Fantus IG, Whiteside CI: Mesangial cell NADPH oxidase upregulation in high glucose is protein kinase C dependent and required for collagen IV expression. Am J Physiol Renal Physiol 2006; 290:F345-F356.
20. 15N] nitrate in biological fluids. Anal Biochem 1982; 126: 131-138.
21. Dusse LMSA, Silva RMM, Vieira LM, Carvalho MG: Does plasma nitrite determination by the Griess reaction reflect nitric oxide synthesis? Clin Chim Acta 2005; 362: 195-197.
22. Forbes JM, Thallas V, Thomas MC, Founds HW, Burns WC, Jerums G, Cooper ME: The breakdown of preexisting advanced glycation end products is associated with reduced enal fibrosis in experimental diabetes. FASEB J 2003; 17: 1762-1764.
23. Cooper ME, Allen TJ, O'Brien RC, Macmillan PA, Clarke B, Jerums G, Doyle AE: Effects of genetic hypertension on diabetic nephropathy in the rat - functional and structural characteristics. J Hypertens 1988; 6: 1009-1016.
24. Righetti AE, Boer-Lima PA, Lopes de Faria JB: The presence of genetic hypertension stimulates early renal accumulation of fibronectin in experimental diabetes mellitus. Diabetologia 2001; 44: 2088-2091.
25. Silveira LA, Bachi CE, Pinto GA, Lopes de Faria JB: The genetic of hypertension modifies the renal cell replication response induced by experimental diabetes. Diabetes 2002; 51: 1529-1534.
26. Amazonas RB, Lopes de Faria JB: Effects of tight blood pressure control on glomerular hypertrophy in a model of genetic hypertension nd experimental diabetes mellitus. Life Sci 2006; 79: 2135-2143.
27. Amazonas RB, Sanita RA, Kawachi H, Lopes de Faria JB: Prevention of hypertension with and without renin-angiotensin system inhibition precludes nephrin loss in the early stage of experimental diabetes mellitus. Nephron Physiol 2007; 107: 57-64.
28. Cooper ME, Rumble JR, Allen TJ, O'Brien RC, Jerums G, Doyle AE: Antihypertensive therapy in a model combining spontaneous hypertension and diabetes. Kidney Int 1992; 41: 898-903.
29. Cooper ME, Allen TJ, O'Brien RC, Papazoglou D, Clarke E, Jerums G, Doyle AE: Nephropathy in model combining genetic hypertension with experimental diabetes. Enalapril versus hydralazine and metoprolol therapy. Diabetes 1990; 39: 1575-1579.
30. Lehfeld LS, Silveira LA, Ghini B, Lopes de Faria JB: Early blood pressure normalization independent of the class of antihypertensive agent prevents augmented renal fibronectin and albuminuria in experimental diabetic nephropathy. Kidney Blood Press Res 2004; 27: 114-120.
31. Pavan MV, Ghini B, Castro M, Lopes de Faria JB: Prevention of hypertension attenuates albuminuria and renal expression of fibronectin n diabetic spontaneously hypertensive rats. Am J Nephrol 2003; 23: 422-428.
32. Bonnet F, Cooper ME, Kawachi H, Allen TJ, Boner G, Cao Z: Irbesartan normalizes the deficiency in glomerular nephrin expression in a model of diabetes and hypertension. Diabetologia 2001; 44: 874-877.
33. Welch WJ, Mendonca M, Blau J, Karber A, Dennehy K, Patel K, Lao YS, Jose PA, Wilcox CS: Antihypertensive response to prolonged tempol in the spontaneously hypertensive rat. Kidney Int 2005; 68: 179-187.
34. Schnackenberg CG, Welch WJ, Wilcox CS: Normalization of blood pressure and renal ascular resistance in SHR with a membrane-ermeable superoxide dismutase mimetic: role of nitric oxide. Hypertension 1998; 32: 59-64.
35. Craven PA, Studer RK, DeRubertis FR: Impaired nitric oxide-dependent cyclic guanosine monophosphate generation in glomeruli from diabetic rats: evidence for protein kinase C-mediated suppression of cholinergic response. J Clin Invest 1994; 93: 311-320.
36. Komers R, Anderson S: Paradoxes of nitric oxide in the diabetic kidney. Am J Physiol 2003; 284:F1121-F1137.
37. Mitchell JB, Samuni A, Krishna MC, De-Graff WG, Ahn MS, Samuni U, Russo A: Biologically active metal-independent superoxide dismutase mimics. Biochemistry 1990; 29: 2802-2807.
38. Thiemermann C: Membrane-permeable radical scavengers (tempol) for shock, ischemia- reperfusion injury, and inflammation. Crit Care Med 2003;31:S76-S84.
39. Samai M, Sharpe MA, Gard PR, Chatterjee PK: Comparison of the effects of the superoxide dismutase mimetics EUK-134 and tempol on the paraquat-induced nephrotoxicity. Free Radic Biol Res Med 2007; 43: 528-534.
40. Omar BA, McCord JM: The cardioprotective effect of Mn-superoxide dismutase is lost at high doses in the postischemic isolated rabbit heart. Free Radic Biol Med 1990; 9: 473-478.
41. Omar BA, Gad NM, Jordan MC, Striplin SP, Russell WJ, Downey JM, MacCord JM: Cardioprotection by Cu,Zn-superoxide dismutase is lost at high doses in the reoxygenated heart. Free Radic Biol Med 1990; 9: 465-471.
42. McCord JM, Edeas MA: SOD, oxidative stress and human pathologies: a brief history and a future vision. Biomed Pharmacother 2005; 59: 139-142.
43. Fridovich I: Superoxide radical and superoxide dismutases. Annu Rev Biochem 1995; 64: 97-112.
44. Halliwell B: Reactive species and antioxidants. Redox biology is a fundamental theme of aerobic life. Plant Physiol 2006; 141: 312-322.
45. Oury TD, Day BJ, Crapo JD: Extracellular superoxide dismutase in vessels and airways of humans and baboons. Free Radic Biol Med 1996; 20: 957-965.
46. Ookawara T, Imazeki N, Matsubara O, Kizaki T, Oh-Ishi S, Nakao C, Sato Y, Ohno H: Tissue distribution of immunoreactive mouse extracellular superoxide dismutase. Am J Physiol 1998; 275:C840-C847.
47. Adler S, Huang H: Oxidant stress in kidneys of spontaneously hypertensive rats involves both oxidase overexpression and loss of extracellular superoxide dismutase. Am J Physiol Renal Physiol 2004; 287:F907-F913.
48. Fukai T, Siegfried MR, Ushio-Fukai M, Cheng Y, Kojda G, Harrison DG: Regulation of the vascular extracellular superoxide dismutase by nitric oxide and exercise training. J Clin Invest 2000; 105: 1631-1639.
49. 1 in rat hepatocytes. J Biol Chem 1994; 269: 15488-15492.
50. 1 in normal and diabetic rats. Kidney Int 2001; 59: 1342-1353.
51. Zhao W, Chen SS, Chen Y, Ahokas RA, Sun Y: Kidney fibrosis in hypertensive rats: role of oxidative stress. Am J Nephrol 2008; 28:548-554.
52. 2+ superoxide dismutase protects against early diabetic glomerular injury in transgenic mice. Diabetes 2001; 50: 2114-2125.
53. DeRubertis FR, Craven PA, Melhem MF, Salah EM: Attenuation of renal injury in db/db mice overexpressing superoxide dismutase: evidence for reduced superoxide-nitric oxide interaction. Diabetes 2004;53:762-768.
54. DeRubertis FR, Craven PA, Melhem MF: Acceleration of diabetic renal injury in the superoxide dismutase knockout mouse: effects of tempol. Metab Clin Exp 2007; 56: 1256-1264.
55. Lin C-L, Wang F-S, Kuo Y-R, Huang Y-T, Huang H-C, Sun Y-C, Kuo Y-H: Ras modulation of superoxide activates ERK-dependent fibronectin expression in diabetes-induced renal injuries. Kidney Int 2006; 69: 1593-1600.
56. Facchini FS, Saylor KL: A low-iron-available, polyphenol-enriched, carbohydraterestricted diet to slow progression of diabetic nephropathy. Diabetes 2003; 52: 1204-1209.
57. Rodrigo R, Rivera G: Renal damage mediated by oxidative stress: a hypothesis of protective effects of red wine. Free Radic Biol Med 2002; 33: 409-422.